These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1352812)

  • 1. Absorption kinetics of cyclosporin in the rat.
    Hedayati S; Bernareggi A; Rowland M
    J Pharm Pharmacol; 1992 Feb; 44(2):122-4. PubMed ID: 1352812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and absolute bioavailability of cyclosporin following intravenous and abomasal administration to sheep.
    Charles BG; Filippich LJ; Pass MA
    J Pharm Pharmacol; 1993 Sep; 45(9):821-4. PubMed ID: 7903372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporin pharmacokinetics after intravenous and oral administration in patients with Crohn's disease.
    Brynskov J; Freund L; Campanini MC; Kampmann JP
    Scand J Gastroenterol; 1992 Nov; 27(11):961-7. PubMed ID: 1455195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of oral adsorbent AST-120 on cyclosporin absorption in rats.
    Takemoto M; Tsuchida M; Konishi M; Suga A; Iojima K; Naito K
    J Pharm Pharmacol; 1997 Jul; 49(7):657-60. PubMed ID: 9255707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decrease in oral bioavailability of cyclosporin A by coadministration of probucol in rats.
    Sugimoto K; Sakamoto K; Fujimura A
    Life Sci; 1997; 60(3):173-9. PubMed ID: 9000641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung deposition and pharmacokinetics of cyclosporine after aerosolization in lung transplant patients.
    Burkart GJ; Smaldone GC; Eldon MA; Venkataramanan R; Dauber J; Zeevi A; McCurry K; McKaveney TP; Corcoran TE; Griffith BP; Iacono AT
    Pharm Res; 2003 Feb; 20(2):252-6. PubMed ID: 12636164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of cyclosporin A absorption in rat small bowel and the effect of bile.
    Cakaloglu Y; Marinos G; Marsden J; Peters TJ; Williams R; Tredger JM
    Clin Sci (Lond); 1993 Jun; 84(6):675-9. PubMed ID: 8334815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circadian changes in pharmacokinetics of cyclosporin in healthy volunteers.
    Choi JS; Park HJ
    Res Commun Mol Pathol Pharmacol; 1999 Jan; 103(1):109-12. PubMed ID: 10440576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marked decrease of cyclosporin bioavailability caused by coadministration of ginkgo and onion in rats.
    Yang CY; Chao PD; Hou YC; Tsai SY; Wen KC; Hsiu SL
    Food Chem Toxicol; 2006 Sep; 44(9):1572-8. PubMed ID: 16762474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of terbinafine on the pharmacokinetics of cyclosporin in humans.
    Long CC; Hill SA; Thomas RC; Johnston A; Smith SG; Kendall F; Finlay AY
    J Invest Dermatol; 1994 May; 102(5):740-3. PubMed ID: 8176256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Marked decrease of cyclosporin absorption caused by phellamurin in rats.
    Chen HY; Wu TS; Su SF; Kuo SC; Chao PD
    Planta Med; 2002 Feb; 68(2):138-41. PubMed ID: 11859464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose dependent absorption and linear disposition of cyclosporin A in rat.
    Lindberg-Freijs A; Karlsson MO
    Biopharm Drug Dispos; 1994 Jan; 15(1):75-86. PubMed ID: 8161718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of gastrointestinal inflammation and age on the pharmacokinetics of oral microemulsion cyclosporin A in the first month after bone marrow transplantation.
    Schultz KR; Nevill TJ; Balshaw RF; Toze CL; Corr T; Currie CJ; Strong DK; Keown PA
    Bone Marrow Transplant; 2000 Sep; 26(5):545-51. PubMed ID: 11019845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of pharmacokinetic interaction between cyclosporin A and probucol in rats.
    Jiko M; Yano I; Wakasugi H; Saito H; Inui K
    Pharm Res; 2002 Sep; 19(9):1362-7. PubMed ID: 12403074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of in-vivo transdermal absorption of cyclosporin with absorption enhancer using intradermal microdialysis in rats.
    Nakashima M; Zhao MF; Ohya H; Sakurai M; Sasaki H; Matsuyama K; Ichikawa M
    J Pharm Pharmacol; 1996 Nov; 48(11):1143-6. PubMed ID: 8961162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Grapefruit juice effects on the bioavailability of cyclosporin-A in rats.
    Mangano NG; Cutuli VM; Caruso A; De Bernardis E; Amico-Roxas M
    Eur Rev Med Pharmacol Sci; 2001; 5(1):1-6. PubMed ID: 11860217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic and intratubular effects of cyclosporin-A and tacrolimus on the rat kidney.
    Romano G; Cavarape A; Favret G; Bortolotti N; Bartoli E
    Eur J Pharmacol; 2000 Jul; 399(2-3):215-21. PubMed ID: 10884522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition of intravenous and oral cyclosporine after administration with grapefruit juice.
    Ducharme MP; Warbasse LH; Edwards DJ
    Clin Pharmacol Ther; 1995 May; 57(5):485-91. PubMed ID: 7768070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased cyclosporin A absorption after treatment with GoLytely lavage solution in rats.
    Santa T; Nishihara K; Horie S; Kotaki H; Sawada Y; Kawabe K; Iga T
    J Pharm Pharmacol; 1994 Jul; 46(7):606-7. PubMed ID: 7996392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the six-mer synthetic peptide (AT1002) fragment of zonula occludens toxin on the intestinal absorption of cyclosporin A.
    Song KH; Fasano A; Eddington ND
    Int J Pharm; 2008 Mar; 351(1-2):8-14. PubMed ID: 17954018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.